BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/27/2026 7:12:39 AM | Browse: 3 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Naringenin pretreatment attenuates hepatic ischemia-reperfusion injury by activating the PI3K-Akt signaling pathway
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jian-Sen Lu, Hong-Liang Liang, De-Cheng Chen, Hao Pan, Tian Han, Wei-Ye Zhang, Meng Fan, Wen Hou and Zhong-Yang Shen |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Tianjin City |
23JCZDJC01070 |
| Tianjin Key Medical Discipline Construction Project |
TJYXZDXK-3-006A, TJYXZDXK-3-005A |
| National Natural Science Foundation of China |
82241219 |
| National Major Scientific Research Instrument Development Project of China |
82127808 |
|
| Corresponding Author |
Zhong-Yang Shen, Tianjin Organ Transplantation Research Center, Institute of Transplantation Medicine, Tianjin First Central Hospital, Nankai University, No. 94 Fukang Road, Nankai District, Tianjin 300071, China. zhongyangshen@nankai.edu.cn |
| Key Words |
Hepatic ischemia-reperfusion injury; Naringenin; Phosphatidylinositol 3-kinase-protein kinase B signaling pathway; Oxidative stress; Apoptosis; Inflammatory response |
| Core Tip |
The specific protective effects and underlying molecular mechanisms in hepatic ischemia-reperfusion injury remain to be systematically elucidated. This study demonstrates that naringenin protects the liver from ischemia-reperfusion injury by inhibiting oxidative stress, inflammatory response, and hepatocyte apoptosis, with the phosphatidylinositol 3-kinase-protein kinase B signaling pathway serving as a key regulatory axis. |
| Citation |
Lu JS, Liang HL, Chen DC, Pan H, Han T, Zhang WY, Fan M, Hou W, Shen ZY. Naringenin pretreatment attenuates hepatic ischemia-reperfusion injury by activating the PI3K-Akt signaling pathway. World J Gastroenterol 2026; In press |
 |
Received |
|
2025-12-22 09:07 |
 |
Peer-Review Started |
|
2025-12-22 09:07 |
 |
First Decision by Editorial Office Director |
|
2026-01-22 08:57 |
 |
Return for Revision |
|
2026-01-22 08:57 |
 |
Revised |
|
2026-02-04 10:41 |
 |
Publication Fee Transferred |
|
2026-02-05 21:37 |
 |
Second Decision by Editor |
|
2026-04-27 02:30 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-04-27 07:12 |
 |
Articles in Press |
|
2026-04-27 07:12 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345